Dikhyaa Mohanty 
Covaxin, India’s first indigenous COVID-19 vaccine, is expected to be available for children by September as informed by Delhi AIIMS chief Dr Randeep Guleria.
According to the report, Dr Randeep Guleria stated that Covaxin’s data for children after completion of the Phase 2/3 trials will be available by September and the approval is expected the same month.
Further, he added that if Pfizer-BioNTech’s vaccine receives approval in India then that can also be one of the options for children. On June 7, Delhi AIIMS started vaccine clinical trials on kids between the age of 2 to 17.
In May, the Drugs Controller General of India (DCGI) had granted permission to Bharat Biotech to commence phase 2-3 trials of Covaxin on children as young as two.
Earlier Guleria had warned that the third wave of COVID-19 can strike India in the next six to eight weeks if crowds are not prevented and if rules are broken. He stated that If Covid-appropriate behaviour is not followed, the third wave can happen in six to eight weeks.
